Difference between revisions of "Atrophy of the prostate gland"

From Libre Pathology
Jump to navigation Jump to search
 
Line 9: Line 9:
| LMDDx      = [[prostate carcinoma]] - esp. [[atrophic prostate carcinoma]], [[atypical small acinar proliferation]]
| LMDDx      = [[prostate carcinoma]] - esp. [[atrophic prostate carcinoma]], [[atypical small acinar proliferation]]
| Stains    =
| Stains    =
| IHC        = AMACR -ve, p63 +ve (basal cells), CK34betaE12 +ve (basal cells)
| IHC        = [[AMACR]] -ve, [[p63]] +ve (basal cells), [[CK34betaE12]] +ve (basal cells)
| EM        =
| EM        =
| Molecular  =
| Molecular  =

Latest revision as of 14:50, 4 August 2022

Atrophy of the prostate gland
Diagnosis in short

Atrophic prostatic glands. H&E stain.
LM glands typically have a jagged edges/prows (in cancer the glands tend to have round edges), gland density is usually lower than in prostate carcinoma (glands are not back-to-back), nuclei small & hyperchromatic, scant cytoplasm
LM DDx prostate carcinoma - esp. atrophic prostate carcinoma, atypical small acinar proliferation
IHC AMACR -ve, p63 +ve (basal cells), CK34betaE12 +ve (basal cells)
Site prostate gland
Symptoms none
Prevalence very common
Prognosis benign
Treatment none

Atrophy of the prostate gland, also prostatic atrophy, is a common change in the prostate gland.

General

Classification

It can be classified into:[4]

  1. Focal prostatic atrophy.
  2. Diffuse prostatic atrophy.

Focal atrophy can be subclassified as:[4]

  1. Partial.
  2. Complete.
  3. Combined.

Microscopic

Features:

  • Glands often have a jagged edges/prows (in cancer the glands tend to have round edges) - key feature.
    • Prow = forward most part of a ship's bow that cuts through the water.[5]
      • You may have come across prow in the context of breast cancer, i.e. tubular carcinoma.
  • Gland density is usually lower than in prostate carcinoma, i.e. glands are not back-to-back - key feature.
  • Atrophic glands are often hyperchromatic.[6]
  • Scant cytoplasm - usually.

Negatives:

  • Nuclei like normal, i.e. nucleoli uncommon.
  • Should have two cell layers, i.e. epithelial and myoepithelial (may be difficult to see).

Notes:

  • Atrophic glands may be scattered with non-atrophic ones.
  • IHC may be misleading - basal cell loss.

DDx:

Atrophy versus cancer

Histologic feature Atrophy Cancer
Glandular architecture/
arrangement 		angulated glands, may
look like they originate
from one large duct 		round glands,
often back-to-back
Nuclear
hyperchromasia 		marked moderate
Cytoplasm scant/minimal moderate, may
be amphophilic
Basal cells may be visible absent
Nucleoli absent present
Secretions in
glands 		no yes - eosinophilic
or blue

Images

  • APG - low mag. (WC)

  • APG - intermed. mag. (WC)

  • APG - high mag. (WC)

  • APG - very high mag. (WC)

www:

IHC

  • Classically like normal prostate (AMACR -ve, p63 +ve, CK34betaE12 +ve).
    • May be negative for basal cell markers, i.e. p63 and CK34betaE12.[1]

Sign out

Generally, this finding is not reported; it is considered a normal finding. 

Left Apex:
- Benign prostate tissue with glandular atrophy.

Micro

The core shows rare, spaced, atrophic appearing glands, mostly with a wavy border and a decreased quantity of cytoplasm. Prominent nucleoli and significant nuclear enlargement are not identified.

There are none of the following: mitoses, adjacent PIN, suspicious luminal material, nuclear hyperchromasia.

See also

References

  1. ↑ 1.0 1.1 Wang, W.; Sun, X.; Epstein, JI. (Jun 2008). "Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.". Am J Surg Pathol 32 (6): 851-7. doi:10.1097/PAS.0b013e31815a0508. PMID 18408595. Cite error: Invalid <ref> tag; name "pmid18408595" defined multiple times with different content
  2. ↑ De Marzo, AM.; Marchi, VL.; Epstein, JI.; Nelson, WG. (Dec 1999). "Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.". Am J Pathol 155 (6): 1985-92. doi:10.1016/S0002-9440(10)65517-4. PMID 10595928.
  3. ↑ Celma, A.; Servián, P.; Planas, J.; Placer, J.; Quilez, MT.; Arbós, MA.; de Torres, I.; Morote, J. (Mar 2014). "Clinical Significance of Proliferative Inflammatory Atrophy in Prostate Biopsy.". Actas Urol Esp 38 (2): 122-126. doi:10.1016/j.acuro.2013.04.008. PMID 24129226.
  4. ↑ 4.0 4.1 Billis, A.. "Prostatic atrophy. Clinicopathological significance.". Int Braz J Urol 36 (4): 401-9. PMID 20815946.
  5. ↑ http://en.wikipedia.org/wiki/Prow
  6. ↑ SN. June 3, 2009.
Retrieved from "https://librepathology.org/w/index.php?title=Atrophy_of_the_prostate_gland&oldid=52103"